Bae J, Martinson JA, Klingemann H-G. Identification of CD19 and CD20 peptides for induction of antigen-specific lymphocytes against B-cell malignancies. Clin Cancer Res 11: 1629-1638, 2005

Xiulong X, Rao G, Gaffud MJ, Ding HG, Maki G, Klingemann H-G, Groh V, Spies T, Caillat-Zucman S, Gattuso P, Plate J, Prinz RA. Clinicopathological significance of major histocompatibility complex class I related chain A and B (MICAA/B) expression in thyroid cancer. J Clin Endocrinol Metabol 91:2704-12, 2006

Klingemann H, Rainov NG, Smythe JA , Touitou E. Editorial Board Focus 2007. Expert Opin Biol Ther 7: 573-5: 2007

Mueller T, Uherek C, Maki G, Chow KU, Schimpf A. Klingemann H-G, Tonn T, Wels WS. Expression of a CD20-specific antigen receptor enhances activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells. Cancer Immunol Immunother, DOI 10.1007/s00262-007-0383-3

Friedman R., Betancur M, Tuncer H, Boissel L. Klingemann, H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation, Biol Blood Marrow Transplant, Biol Blood Marrow Transplant, 2007: 13: 1477-1486